Category: Endocrine Surgery

Swallowing Woes Post-Thyroid Surgery: A Senior’s Struggle

Unveiling the scoop on older adults, researchers spill the tea on dysphagia after thyroid and parathyroid surgery. Surveying 175 patients, aged 65 on average, they found 77.7% reported pre-op swallowing troubles, 22.4% more in frail folks. Post-op, 43.4% and 49.1% faced worse scores at 3 and 6 months. Pre-op dysphagia meant a 3.07-fold risk of […]

Adrenal Cancer Secrets: Mixed Hormonal Tumors Spell Trouble

In a hip multicenter study, researchers spilled the tea on adrenal cancer secrets. Analyzing 807 patients, they unveiled that mixed cortisol/androgen-secreting adrenal tumors play hard on survival, with worse overall survival compared to solo cortisol or androgen secrets. Notably, after a clean R0 surgery, the secretory subtype didn’t sway overall survival. Cortisol-secreting tumors spilled more […]

High-Volume Parathyroid Surgeons: A Dearth in Accessibility

The hunt for equitable healthcare takes center stage as researchers uncover disparities in access to high-volume parathyroid surgeons in the US. Analysis of 2019 Medicare data reveals a skewed distribution, with 445 identified surgeons mostly concentrated in metropolitan areas. Shockingly, disadvantaged neighborhoods face longer distances to these specialists, potentially impacting treatment outcomes for hyperparathyroidism patients. […]

Social Vulnerability Delays Treatment: Impact on Primary Hyperparathyroidism Evaluation

In a Massachusetts study on primary hyperparathyroidism, researchers found that patients in socially vulnerable groups faced delays in surgeon evaluation, contributing to heightened risks of long-term complications. Among 1,082 patients, those in the highest vulnerability quartile had a 33% lower surgeon evaluation rate and were seen 67 days later than those in the lowest quartile. […]

Tumor Biology and Surgical Margins Dictate Survival in Non-Metastatic Adrenocortical Carcinoma: A Paradigm Shift

In the battle against adrenocortical carcinoma (ACC), researchers find surgical approach and extent matter less than tumor biology and margins in non-metastatic cases. A cohort study (2010–2019, 1,175 subjects) reveals laparoscopic surgery, often considered minimally invasive, correlates with worse survival in advanced disease (stage III). Positive margins negatively impact survival, while chemoradiation benefits those with […]

Surgery Shines: A Viable Treatment Avenue for Stage IE Primary Thyroid Lymphoma

Surgery emerges as a viable treatment for stage IE primary thyroid lymphoma (PTL), with a cohort study of 1,596 patients (SEER database) and an external cohort of 38 patients (Shanghai, China). The 7.8-year SEER analysis showed no significant survival difference between surgery, surgery + radiotherapy/chemotherapy, and radiotherapy/chemotherapy alone. In the external cohort, surgery-alone exhibited comparable […]

Sex concordance increased specialist evaluations, potentially addressing under-referral issues in primary hyperparathyroidism.

Investigating primary hyperparathyroidism referrals, a study analyzed 1,100 patients and found that sex concordance (matching patient and practitioner sexes) correlated with increased specialist evaluations. Patients with concordant primary care practitioners had 32% higher odds of endocrinologist evaluation, and those with concordant endocrinologists had a 48% higher rate of surgeon evaluation. Stratified analysis revealed that sex […]

Thyroid-Stimulating Hormone Receptor Identified as a Promising Imaging Target for Differentiated Thyroid Cancer

In the realm of thyroid cancer, where iodine treatment falls short for some, researchers explored a new ally. The thyroid-stimulating hormone receptor (TSHR) took the spotlight, showing up in 62% of patients’ thyroid tissues. With a specially crafted radiolabeled compound, researchers witnessed TSHR’s potential for imaging differentiated thyroid cancer. This breakthrough hints at a fresh […]

Comparing Total Thyroidectomy Methods: Emphasizing EOA’s Superiority in Surgical Integrity and Patient Comfort

In treating differentiated thyroid cancer, various surgical methods were compared for integrity, safety, efficacy, and patient experience. The study, including 7042 patients, found that the endoscopic transoral approach (EOA) excelled in maintaining surgical integrity and minimizing pain. Robotic bilateral axillo-breast approach (RBABA) protected parathyroid glands and the recurrent laryngeal nerve but had the longest operative […]

Rocking the Papillary Thyroid Carcinoma Scene: Radiofrequency Ablation’s Long-Term Triumph

A groundbreaking study tracked 1613 patients with low-risk papillary thyroid carcinoma (PTC) who underwent radiofrequency ablation (RFA) for an impressive 58.5 months. Results unveiled a remarkable 4.3% local tumor progression rate, with a 95.7% disease-free survival at 8 years. Subcapsular tumor location and multifocality were risk factors, emphasizing RFA’s efficacy. Unifocal, smaller tumors correlated with […]